Cargando…

Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report

BACKGROUND: With the wide application of immune checkpoint inhibitors (ICIs) in cancer treatment, immune-related adverse events occur frequently, involving almost all organs and systems. The incidence of ICI-associated arthritis (IA) is unknown. In most cases, IA is not serious and non-lethal. Highe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yan, Huang, Xiao-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602251/ https://www.ncbi.nlm.nih.gov/pubmed/36312471 http://dx.doi.org/10.12998/wjcc.v10.i29.10701

Ejemplares similares

A case of pulmonary adenocarcinoma showing rapid progression of peritoneal dissemination after immune checkpoint inhibitor therapy
por: Shinozaki, Taro, et al.
Publicado: (2018)

Immune checkpoint inhibitor‐induced asthma and chronic obstructive pulmonary disease overlap in patient with adenocarcinoma
por: Hayakawa, Yuki, et al.
Publicado: (2023)

Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review
por: Sun, Yansha, et al.
Publicado: (2022)

Case of advanced pulmonary squamous cell carcinoma cured by resection through preoperative induction of immune checkpoint inhibitor
por: Kawai, Hideki, et al.
Publicado: (2018)

Immune Checkpoint Inhibitor–Associated Sarcoidosis Reaction in the Kidney: Case Report
por: Charkviani, Mariam, et al.
Publicado: (2023)

Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy
por: Glick, Matthew, et al.
Publicado: (2020)

Late relapse of IgM nephropathy‐associated nephrotic syndrome after repeated administration of immune checkpoint inhibitor against pulmonary adenocarcinoma
por: Odani, Kentaro, et al.
Publicado: (2021)

Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report
por: Miura, Naoko, et al.
Publicado: (2020)

Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
por: Lee, Ahlim, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

Immune checkpoint inhibitors‐induced eosinophilic pneumonia: A case report
por: Hara, Kanako, et al.
Publicado: (2021)

Case Report: Cardiac Toxicity Associated With Immune Checkpoint Inhibitors
por: Chen, Ru, et al.
Publicado: (2021)

Lung adenocarcinoma with tumor resolution and dystrophic calcification after salvage surgery following immune checkpoint inhibitor therapy: A case report
por: Sumi, Toshiyuki, et al.
Publicado: (2020)

Advances in immune checkpoint inhibitors induced-cardiotoxicity
por: Li, Xiang, et al.
Publicado: (2023)

Encephalomyeloneuritis and arthritis after treatment with immune checkpoint inhibitors
por: Nowosielski, Martha, et al.
Publicado: (2020)

Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report
por: Zhong, Peng, et al.
Publicado: (2023)

Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinoma
por: Nakahama, Kenji, et al.
Publicado: (2022)

Pathological Complete Response after Immune-Checkpoint Inhibitor Followed by Salvage Surgery for Clinical Stage IV Pulmonary Adenocarcinoma with Continuous Low Neutrophil-to-Lymphocyte Ratio: A Case Report
por: Higuchi, Mitsunori, et al.
Publicado: (2021)

Management of pulmonary toxicity associated with immune checkpoint inhibitors
por: Delaunay, Myriam, et al.
Publicado: (2019)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
por: Abu Khalaf, Suha, et al.
Publicado: (2020)

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review
por: Murakami, Shoko, et al.
Publicado: (2019)

Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
por: Zhang, Zhe, et al.
Publicado: (2022)

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
por: Fletcher, James, et al.
Publicado: (2022)

A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab
por: Bloomer, Chance H., et al.
Publicado: (2022)

Pulmonary Complications Secondary to Immune Checkpoint Inhibitors
por: Albitar, Hasan Ahmad Hasan, et al.
Publicado: (2020)

A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer
por: Yan, Yi-Dan, et al.
Publicado: (2021)

Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
por: Chen, Yue, et al.
Publicado: (2022)

Guillain-Barre Syndrome in a patient with uterine adenocarcinoma undergoing treatment with immune-checkpoint inhibitor therapy: A case report and review of the literature
por: Brzezinska, Bogna N., et al.
Publicado: (2021)

Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis
por: Oke, Anuoluwapo R, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma
por: Lynch, Emer, et al.
Publicado: (2023)

Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
por: Akhuba, Liia, et al.
Publicado: (2023)

Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report
por: Hakozaki, Taiki, et al.
Publicado: (2018)

Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report
por: Yao, Yanhong, et al.
Publicado: (2022)

Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019
por: Liu, Jiaqing, et al.
Publicado: (2020)

Advanced Research on Immune Checkpoint Inhibitor Therapy
por: Imai, Hisao, et al.
Publicado: (2022)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
por: Han, Ji Won, et al.
Publicado: (2021)

Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
por: Tanabe, Junya, et al.
Publicado: (2020)

Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
por: Wang, Feifei, et al.
Publicado: (2021)

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis
por: Ponce, Andrés, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jpml5ti9btui3h20o1i175lis3